Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation.
Homeoproteins are transcription factors that act as master regulators of development and are frequently dysregulated in cancers. During embryogenesis, the Six1 homeoprotein is essential for the expansion of precursor cell populations that give rise to muscle and kidney, among other organs. Six1 overexpression is observed in numerous cancers, resulting in increased proliferation, survival, and metastasis. Here, we investigate whether Six1 can play a causal role in mammary tumor initiation. We show that Six1 overexpression in MCF12A mammary epithelial cells promotes multiple properties associated with malignant transformation, including increased proliferation, genomic instability, and anchorage-independent growth. We further show that this transformation is dependent on up-regulation of its transcriptional target, cyclin A1, which is normally expressed in the embryonic mammary gland but dramatically reduced in the adult gland. Six1-transformed MCF12A cells are tumorigenic in nude mice, forming aggressive tumors that are locally invasive and exhibit peritumoral lymphovascular invasion. In human breast carcinomas, expression of Six1 and cyclin A1 mRNA correlate strongly with each other (P < 0.0001), and expression of Six1 and cyclin A1 each correlate with Ki67, a marker of proliferation (P < 0.0001 and P = 0.014, respectively). Together, our data indicate that Six1 overexpression is sufficient for malignant transformation of immortalized, nontumorigenic mammary epithelial cells, and suggest that the mechanism of this transformation involves inappropriate reexpression of cyclin A1 in the adult mammary gland.
Coletta
Ricardo D
RD
Department of Obstretrics and Gynecology, University of Colorado Health Sciences Center, Aurora, Colorado 80045, USA.
Christensen
Kimberly L
KL
Micalizzi
Douglas S
DS
Jedlicka
Paul
P
Varella-Garcia
Marileila
M
Ford
Heide L
HL
D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D048708:Cell Growth Processes / Q000502:physiology; D002471:Cell Transformation, Neoplastic / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D019925:Cyclin A / Q000096:biosynthesis / Q000235:genetics; D056750:Cyclin A1; D004249:DNA Damage; D004847:Epithelial Cells / Q000473:pathology; D005347:Fibroblasts / Q000502:physiology; D042822:Genomic Instability; D018398:Homeodomain Proteins / Q000096:biosynthesis*; D006801:Humans; D042361:Mammary Glands, Human / Q000378:metabolism / Q000473:pathology / Q000502:physiology; D051379:Mice; D041681:NIH 3T3 Cells
C503745:CCNA1 protein, human; D019925:Cyclin A; D056750:Cyclin A1; D018398:Homeodomain Proteins; C099236:SIX1 protein, human